*By Conor White*
In the wake of a data breach at MyHeritage that affected more than 90 million users, other DNA-testing services are trying to assure customers their personal information is secure.
"Ultimately, the amount of care that companies go to is really important," explained David Nicholson, co-founder and managing director of Living DNA, which provides customers information on where their ancestors come from. "But you should always look at the company you're going to test your DNA with, or store your DNA with, and decide where you're going to put that information."
The recent furor over security comes after MyHeritage disclosed last week it learned that the email addresses and encrypted passwords of 92.3 million users had been leaked to a private server last October. In an interview Monday on Cheddar, Nicholson said accessing an individual's actual DNA would be much more difficult.
"Any of these firms don't actually store your DNA data, which you could use to identify you publicly on a website. That's all kept securely on encrypted servers way behind the scenes."
While Living DNA is doing its best to protect user data from malicious actors, Nicholson also reassured customers that their data would never be willingly given to anyone looking to profit off of it.
"We will absolutely never sell data, never pass it on," he said. "We are custodians of your data, and therefore it's kept secure, safe, and encrypted for you, never to be sold."
For full interview, [click here](https://cheddar.com/videos/how-safe-is-your-information-with-a-dna-testing-service).
Shelli Avenevoli, Ph.D., the deputy director for the National Institute of Mental Health (NIMH), joined Cheddar to discuss concerns about the devastating impact the pandemic has had on the nation's youth. While mental health issues have been a point of concern for the populace at large, Avenevoli talked about how vulnerable young people have been during the COVID-19 crisis. "It's important to keep in mind, for children and adolescents, that the pandemic is occurring during a time of very formative development when social connection is vital for health and optimal function," she said. Avenevoli also noted broad political and social upheavals that have contributed to the issue but also things that can be done to help minors with their mental wellbeing.
Cheddar Innovates gets a look at the satellite that's searching for the earliest light from the big bang, plus a former Nike executive breaks down what the new era of sportswear looks like.
A packed Thursday pod: Carlo and Baker cover the latest developments in the Ghislaine Maxwell, Jussie Smollett and Elizabeth Holmes trials. Plus, Dems are losing the Hispanic vote, Boris Johnson in trouble again, and is it possible that Adele has peaked?
A mental health crisis among young people is looming, and a large part of it is online. Cheddar News speaks with digital policy expert Karen Kornbluh on the issue.
Adam Mosseri, head of Instagram, faced withering questions on Capitol Hill about the reports the social media app was aware of the severe mental health impacts it was having on teenage girls. Karen Kornbluh, the director of digital innovation and democracy for the German Marshall Fund, joined Cheddar to discuss the rare show of bipartisan outrage on display at the Senate hearing. "The senators came really loaded for bear on both sides of the aisle," she said. Kornbluh explained how senators like Richard Blumenthal (D-Conn.) set up fake Instagram accounts with teen girl profiles in order to research the effects firsthand.
Back in 2010, several large companies pledged to work towards stopping deforestation by 2020. Companies like Nestle and Carrefour even went further to say that they would eliminate deforestation from their supply chains altogether. However, fast forward to 2020, many of these companies have failed to reach that goal. Associate Director of Forest at the CDP Nadia Bishai, joined Cheddar to discuss more.
A new study by Pfizer-BioNTech found that a third dose of their COVID-19 vaccine is effective against the emerging omicron variant. The pharmaceutical giants also look to manufacture a vaccine specific to the omicron variant by March 2022.
